Analyst Observations
Published: June 18, 2025
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
ALNY, DELL, LYV, PLNT, SCHW, SMCI, THC, TMO, & V.

 

ALNY Alnylam Pharmaceuticals Inc. ($312.84) - Biomedics/Genetics - ALNY moved higher to break a double at $312, marking its third consecutive buy signal and a new all-time high above $316. The 5 for 5'er moved into a positive trend last month and ranks in the top quintile of the biomedics/genetics. The weekly OBOS indicates that the stock is in overbought territory. Consider waiting for a pullback or dollar-cost average into the position, as the 10-week trading band normalizes. Initial support is at $296, with additional support at $248
DELL Dell Technologies Inc Class C ($116.95) - Computers - DELL advanced Wednesday to break a quadruple top at $118. This 3 for 5'er has shown consistent improvement since moving back to a positive trend in late April. The weight of the technical evidence is mixed but continues to improve. Initial support can be seen at $110 and $108 from earlier this month.
LYV Live Nation Entertainment Inc. ($148.58) - Leisure - LYV broke a double top at $146 to complete a bullish triangle for a third buy signal as shares rallied to $148. The stock is a 4 for 5'er that ranks in the top quintile of the Leisure sector matrix. Okay to consider here on the breakout. Note resistance at current levels, while additional resides at $156, the all-time chart high.
PLNT Planet Fitness Inc ($108.11) - Leisure - PLNT reversed into Xs and broke a double top at $108 for a third buy signal and to match the all-time chart high. The stock is a 5 for 5'er that ranks within the top quintile of the Leisure sector matrix. Okay to consider here on the breakout. Initial support lies at $100, while additional can be found in the mid to lower $90s.
SCHW The Charles Schwab Corporation ($89.93) - Wall Street - SCHW shares moved higher today to break a double top at $90 to mark its second consecutive buy signal. This 5 for 5'er has been in a positive trend since April and on an RS buy signal versus the market since May. SCHW shares are actionable at current levels. From here, support is offered at $86.
SMCI Super Micro Computer, Inc. ($44.93) - Computers - SMCI pushed higher Wednesday to break a triple top at $45, notching a second consecutive buy signal. This 5 for 5'er moved to a positive trend in May and sits in the top quartile of the computers sector RS matrix. The weight of the technical evidence is favorable and improving. Initial support can be seen at $41, which is also the current location of the bullish support line.
THC Tenet Healthcare Corporation ($167.97) - Healthcare - THC inched higher to break a double top at $170. The 5 for 5'er moved up from a 4 last month after showing short-term relative strength against the market. Additionally, THC ranks in the top decile of the healthcare sector matrix. Long exposure can be considered here. Initial strong support is at $154-$156, with additional support at $110.
TMO Thermo Fisher Scientific Inc. ($393.43) - Healthcare - TMO inches lower to break a triple bottom at $388, marking a multi-year low. The 1 for 5'er moved into a negative trend in February and is down over -20% year-to-date. Additionally, the stock ranks at the bottom of the healthcare sector matrix. Sell your position here. Initial resistance is at $424, with some additional possible resistance at $448.
V Visa Inc. ($339.78) - Finance - V shares fell today to break a double bottom at $344 to mark its second consecutive sell signal. This 5 for 5'er has been in a positive trend since October 2022 and on an RS buy signal versus the market since November 2021. V shares are trading in normalized territory near the middle of their trading band. From here, support is offered at $340.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-{ENDYEAR} Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright